Aims/hypothesis Insulin signalling pathways regulate pancreatic beta cell function. Conditional gene targeting using the Cre/loxP system has demonstrated that mice lacking insulin receptor substrate 2 (IRS2) in the beta cell have reduced beta cell mass. However, these studies have been complicated by hypothalamic deletion when the RIPCre (B6.Cg-tg(Ins2-cre) 25Mgn/J) transgenic mouse (expressing Cre recombinase under the control of the rat insulin II promoter) is used to delete floxed alleles in insulin-expressing cells. These features have led to marked insulin resistance making the beta cellautonomous role of IRS2 difficult to determine. To establish the effect of deleting Irs2 only in the pancreas, we generated PIrs2KO mice in which Cre recombinase expression was driven by the promoter of the pancreatic and duodenal homeobox factor 1 (Pdx1, also known as Ipf1) gene.
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Introduction
Insulin regulates peripheral energy homeostasis by acting on multiple tissues to control carbohydrate, lipid and protein metabolism [1] . It has also been demonstrated that insulin receptor and post-receptor signalling mechanisms are required for pancreatic beta cell function [2] . For example, mice with global deletion of insulin receptor substrate (IRS) 2 develop type 2 diabetes due to a combination of insulin resistance and beta cell failure [3, 4] . Furthermore, cell-specific gene targeting in mice using Cre/loxP-mediated recombination strategies has shown that beta cell deletion of the insulin receptor reduces first-phase insulin release and beta cell insulin content and causes a progressive deterioration in glucose tolerance [5] . Deletion of the insulin-like growth factor 1 receptor gene (Igf1r) likewise impairs insulin synthesis and secretion and combined deletion of the insulin receptor gene (Insr) and Igf1r causes marked beta cell failure [6, 7] . Using similar techniques, we and others have recently generated 'beta cell-specific' Irs2-null mice that have utilised a rat insulin promoter 2 Cre recombinase transgenic mouse (RIPCre or B6.Cg-tg(Ins2-cre)25Mgn/J) to delete the floxed alleles of Irs2 [8] [9] [10] [11] . Our studies and those of others have demonstrated that beta cell deletion of Irs2 reduces beta cell mass and impairs glucose tolerance. However, the interpretation of all these studies with respect to the precise role of INSR and IRS2 signalling in beta cell function has been complicated by features of the RIPCre transgenic mouse used to delete the floxed Insr and Irs2 alleles. First, significant Cre recombinase expression in the hypothalamus resulted in the development of obesity, hyperleptinaemia and insulin resistance, which together per se will alter beta cell function [8] [9] [10] . Second, RIPCre mice themselves have been reported to display mild glucose intolerance, although it was unclear whether this was due to the influence of genetic background or the effects of Cre recombinase expression in beta cells [12] . To attempt to circumvent these problems, we have generated mice lacking Irs2 in the pancreas using a mouse in which Cre recombinase expression is driven by the promoter of the pancreatic and duodenal homeobox factor 1 (Pdx1, also known as Ipf1) gene, one of the earliest and most specific endoderm markers of the developing pancreas [13] . These Pdx1-cre mice therefore efficiently delete floxed alleles in the endocrine and exocrine pancreas. Mice lacking Irs2 in Pdx1-expressing cells (PIrs2KO mice) display impaired glucose tolerance with reduced beta and alpha cell mass, impaired insulin secretion, alterations in islet gene expression and beta cell calcium mobilisation but no reduction in insulin sensitivity or body weight alterations. Therefore these results demonstrate that intrinsic pancreatic IRS2 signalling is critical for islet endocrine cell function identifying a novel role for IRS2 in alpha cell function. These effects are independent of the central nervous system and are not due to the use of Cre recombinase technology. Furthermore, we demonstrate that in our hands RIPCre mice do not display glucose intolerance on two mixed genetic backgrounds, suggesting that the RIPCre transgene alone does not cause glucose intolerance.
Materials and methods
Mouse breeding and genotyping strategies Mice with a floxed allele of Irs2 (Irs2 tm1With mice) [8] were intercrossed with Tg(Pdx1-cre)1Herr (Pdx1-cre) mice [13] Pdx1-cre mice. The last of these mice, which lack Irs2 in Pdx1-creexpressing cells, are designated PIrs2KO mice. Mice were maintained on a 12-h light-dark cycle with free access to water and standard mouse chow (4% fat; RM1, Special Diet Services Ltd, Essex, UK) and housed in specific pathogenfree barrier facilities. Mice were handled and all in vivo studies were performed in accordance with the 1986 Home Office Animal Procedures Act (Home Office, London, UK). PIrs2KO mice were studied on a mixed 129Sv/C57Bl/6 background with appropriate litter-mate controls. Wildtype, Cre transgenic and Irs2 tm1With/tm1With mice were phenotypically indistinguishable and mice of these genotypes were used as controls. RIPCre (B6.Cg-tg(Ins2-cre) 25Mgn/J) mice were maintained as previously described [8] . Genotyping of the mice was performed by PCR amplification of tail DNA as described previously [8] .
Metabolic studies Blood samples were collected from mice via tail vein bleeds or from cardiac puncture on terminally anaesthetised mice. Blood glucose, plasma insulin levels, glucose and insulin tolerance tests were performed as previously described [3, 8] . Glucose-stimulated insulin secretion in vivo was performed using an i.p. dose of 3 g/kg of glucose and tail vein bleeds at the times indicated.
Tissue preparation and western blotting Western blotting was performed as previously described [8] . In brief, tissues were homogenised in lysis buffer, solubilised for 30 min on ice and clarified by centrifugation. Supernatant fractions were snap frozen in aliquots and stored at −80°C. For analysis of IRS2 production, tissue extracts (200 μg total protein) were immunoprecipitated for 2 h with polyclonal anti-IRS2 antibody. Immune complexes were collected with 40 μl of a 50% slurry of Protein-A agarose, washed with lysis buffer and resolved on 8% SDS-PAGE and transferred to nitrocellulose. The blots were probed with a polyclonal antibody against IRS2 and enhanced chemiluminescence (Amersham/GE Healthcare UK Ltd, Little Chalfont, UK) detection performed. For other western blots the antibodies used were rabbit anti-forkhead box O1 (FOXO1) (Cell Signaling Technology, Inc., Danvers, MA, USA) and mouse anti-actin (Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA). Sheep anti-GCK antibody was a kind gift from M. Magnuson. Densitometer quantification was undertaken as previously described [14] .
RNA isolation and real-time quantitative RT-PCR RT-PCR was performed as previously described [8] Pancreatic immunocytochemistry and measurement of endocrine cell mass Pancreases were removed, cleared of fat and lymph nodes, fixed in Bouin's solution, embedded in paraffin and cut into 5-μm sections. Insulin and GCG staining and morphometric analysis were performed as previously described [8] . Beta cell proliferation was assessed using Ki67 immunostaining [15] and apoptosis detected using activated caspase 3 immunostaining [16] . Antibodies used were mouse anti-insulin and anti-GCG (Sigma-Aldrich Company Ltd, Poole, UK), rabbit anti-Ki67 and anti-GCG and guinea pig anti-insulin (all Abcam PLC, Cambridge, UK), rabbit anti-active caspase 3 (BD PharMingen, San Diego, CA, USA), rabbit anti-PDX1 (Millipore/Upstate, Dundee, UK), rabbit anti-SST (Millipore/ Chemicon International Inc., Temecula, CA, USA), chicken anti-mouse AlexaFluor 488 and 594, chicken anti-rabbit AlexaFluor 488 and 594 and goat anti-guinea-pig AlexaFluor 546 (all Molecular Probes/Invitrogen, Paisley, UK). Rabbit anti-SCL2A2 antibody was a kind gift from B. Thorens (University of Lausanne).
Islet isolation Mice were killed by cervical dislocation and the common bile duct was cannulated and its duodenal end occluded by clamping. Two millilitres of Liberase (Roche, Basel, Switzerland) solution (0.25 mg/ml in Hanks' balanced salt solution [HBSS] ) were injected into the duct to distend the pancreas. The pancreas was excised, incubated at 37°C for 15 min, and mechanically disrupted in 10 ml HBSS. Cellular components were collected by centrifugation (201 g for 1 min) and re-suspended in 10 ml HBSS. Islets were hand-picked under a microscope and washed once in HBSS. Prior to DNA or protein extraction, islets were centrifuged at 5,724 g for 5 min and stored at −80°C. RNA was extracted from islets using an RNAeasy kit (Qiagen, Hilden, Germany) according to the manufacturer's instructions. For insulin secretion studies, isolated islets were cultured overnight in DMEM with 11 mmol/l glucose supplemented with 10% fetal bovine serum. After a 1-h pre-incubation in HBSS (supplemented with 0.5% BSA and 20 mmol/l HEPES) containing 2 mmol/l glucose, insulin release was assessed by static incubation of groups of eight islets size-matched by handpicking in HBSS containing 2 mmol/l glucose for 30 min, then 11 mmol/l glucose for 30 min, at 37°C with 5% CO 2 . Secreted insulin was assayed using an insulin ELISA kit (Millipore/Linco Research Inc., St Charles, MI, USA). Insulin and GCG were measured in pancreatic extracts by RIA as previously described [17] .
Analysis of calcium fluxes in beta cells by confocal microscopy Islets isolated as above were dissociated into single cells by incubation in trypsin at 21°C for 2.5 min with gentle agitation. Beta cells were washed once before being allowed to attach to poly-L-lysine-treated glass cover-slips. Beta cells were incubated for 48 h in DMEM culture medium with 2 mmol/l L-glutamine supplemented with 10% heat-inactivated fetal bovine serum and 11 mmol/l glucose. The medium was changed to HBSS supplemented with 20 mmol/l HEPES and 2 mmol/l glucose 1 h prior to dye loading. Cells were loaded with 10 μg/ml Fluo3am (Molecular Probes) and 0.025% Pluronic detergent for 30 min and were then imaged on a 37°C heated stage on a Biorad TE300 confocal microscope as glucose concentration was increased from 2 to 11 mmol/l. The response to 200 μmol/l tolbutamide was also determined. Beta cells were identified after imaging by staining with dithizone [18] .
Statistical methods All statistics were performed using GraphPad Prism4 software (Graphpad Software Inc., San Diego, CA, USA) and paired and unpaired t tests and twoway ANOVA with Bonferroni post-tests performed as appropriate. A p value of <0.05 was regarded as significant.
Results
Efficient deletion of Irs2 in the pancreas but not hypothalamus of PIrs2KO mice To assess the sites and extent of the recombination of floxed alleles by the Pdx1-cre mice used in these studies, we analysed DNA extracted from tissues of control and PIrs2KO mice. In PIrs2KO mice, recombination and deletion of the Irs2 allele was detected in DNA from both whole pancreases and isolated islets but not in hypothalamic samples or other tissues (Fig. 1a) . No recombination was seen in tissues from control mice (Fig. 1a) . IRS2 protein was not detected in the pancreas or isolated islets from PIrs2KO mice (Fig. 1b) and Irs2 mRNA was normal in the hypothalamus of these animals (Irs2 mRNA Fig. 1a) and there was no difference in food intake between the genotypes, consistent with the lack of hypothalamic deletion (food intake per mouse [g/24 h]: PIrs2KO mice, 2.9±0.2 vs control, 2.9±0.1, n=6, p=NS). Examination of fasting blood glucose levels at 12 weeks of age showed no significant difference between PIrs2KO mice and control animals in both sexes ( Fig. 1d and ESM  Fig. 1b) . In contrast, random fed blood glucose levels were significantly elevated and glucose tolerance was markedly impaired in 12-week-old male animals (Fig. 1e,f) . Of particular note was that glucose handling in both Pdx1-cre and Irs2 tm1With/tm1With mice was normal, demonstrating no adverse effects of the Pdx1-cre transgene or the loxPflanked Irs2 allele upon glucose homeostasis (Fig. 1f) . Consistent with our previous reports [3, 19] , female mice had a milder glucose homeostasis phenotype than male mice (ESM Fig. 1c) . Fasting insulin levels in 12-week-old PIrs2KO mice were equivalent to control mice, suggesting that PIrs2KO mice are not insulin resistant (Fig. 1g) . Indeed, insulin tolerance tests in PIrs2KO mice revealed no evidence of reduced insulin sensitivity, but at the 60-min time-point a reduced recovery in glucose levels after insulin treatment was seen (Fig. 1h) .
Reduced beta and alpha cell mass in PIrs2KO mice To investigate further the defect in glucose tolerance we measured pancreatic hormone content, determined endocrine cell mass and analysed islet anatomy in PIrs2KO mice. Pancreatic insulin and GCG peptide and islet insulin, Gcg and Sst mRNAs from PIrs2KO mice were reduced (Fig. 2a-c) . Morphometric analysis in 12-week-old PIrs2KO mice revealed a reduced total beta cell and alpha cell mass in these animals but preservation of pancreatic mass (Fig. 2d-f) . However, analysis of beta cell mass in 2-weekold PIrs2KO mice revealed a normal beta cell mass, suggesting that IRS2 was required for the maintenance of a normal adult beta cell mass and not islet development (Fig. 2d) . To understand the basis for the reduced beta cell mass we examined proliferation and apoptosis in these cells. Reduced Ki67 staining was detected in beta cells in PIrs2KO mice, demonstrating reduced proliferation of this cell type (Fig. 2g) , but we observed no increase in apoptosis as determined by staining for activated caspase 3 (Fig. 2g) . Furthermore, islet architecture was preserved with no obvious disruption of the normal organisation of alpha, beta cells or delta cells (Fig. 2h,i) .
Impaired in vivo and in vitro glucose-stimulated insulin secretion in PIrs2KO mice To assess the impact of these abnormalities upon islet function, we analysed glucosestimulated insulin secretion (GSIS) both in vivo and in isolated islets. GSIS in vivo was severely perturbed with loss of first-phase insulin secretion in PIrs2KO mice but was normal in both Pdx1-cre and Irs2 tm1With/tm1With mice (Fig. 3a) . Similarly, in static incubation studies, GSIS was attenuated in islets isolated from PIrs2KO mice (Fig. 3b) .
Gene expression and calcium mobilisation defects in PIrs2KO mice To investigate the mechanisms underlying the secretory defects in PIrs2KO islets, we studied glucosestimulated calcium fluxes in beta cells and analysed the expression of key genes in isolated islets. Examination of calcium fluxes revealed that, in response to an increased glucose concentration, there was a robust increase in intracellular calcium in control beta cells but this was attenuated in PIrs2KO beta cells, consistent with the defects seen in GSIS (Fig. 3c) . Tolbutamide-stimulated calcium release was largely preserved in PIrs2KO beta cells (Fig. 3c) . Foxo1 and Nkx6-1 mRNA levels were significantly reduced but Pdx1 and Neurod1 expression was unchanged (Fig. 3d) . Slc2a2 expression was reduced but Gck expression was unaltered in PIrs2KO islets (Fig. 3d) . Irs1 expression was also unchanged (Fig. 3d) . To assess the impact of these alterations of mRNA levels we examined protein production of SLC2A2, PDX1, GCK, FOXO1 and NKX6-1 in PIrs2KO mice. Immunostaining of islets revealed reduced membrane staining for SLC2A2 in PIrs2KO islets (Fig. 3e) but normal PDX1 staining (ESM Fig. 1d) . Western blotting for FOXO1 demonstrated a trend to reduced protein production (p= 0.07). Likewise there was a non-significant reduction in NKX6-1, but GCK protein was normal (Fig. 3f) .
Normal glucose tolerance in RIPCre mice maintained on two genetic backgrounds As discussed above, it has been suggested that RIPCre (B6.Cg-tg(Ins2-cre)25Mgn/J) transgenic mice develop glucose intolerance in the absence of any gene deletion [12] . This was particularly apparent in mice obtained from the Jackson Laboratory maintained on a C57Bl/6 background. In light of these observations and our findings of normal glucose homeostasis in mice with Cre recombinase expression in islets driven by the Pdx1 promoter, we studied our own colonies of RIPCre mice, which were originally obtained from the Jackson Laboratory but intercrossed with floxed alleles generated with C57Bl/6 mice obtained from other sources as well as other strains. We therefore performed these studies in two mixed genetic backgrounds: 129Sv/C57Bl/6/BALB/c and 129Sv/C57Bl/6. At 12 weeks of age, wild-type and RIPCre littermates of both sexes from the 129Sv/C57Bl/6/BALB/c intercross had identical glucose tolerance (ESM Fig. 1e ). At 24 weeks of age, wild-type and RIPCre littermates of both sexes from the 129Sv/C57Bl/6 intercross had identical glucose tolerance (ESM Fig. 1f) .
Discussion
Through the use of both global and conditional mouse gene targeting strategies we and others have demonstrated that IRS2 plays a key role in the maintenance of pancreatic beta cell mass [3, 4, [8] [9] [10] . Furthermore both INSR and IGF1R have also been demonstrated to act as key regulators of beta cell function using Cre/loxP techniques [5] [6] [7] . However, many of these studies have been compromised by two key features of the RIPCre (B6.Cg-tg(Ins2-cre)25Mgn/J) transgenic mice used to delete the floxed alleles. First, in this animal there was extensive expression in hypothalamic neurons, which resulted in obesity, hyperleptinaemia and hyperinsulinaemia when either Irs2 or indeed Insr was deleted in these cells [8] [9] [10] 20] . Second, it has been suggested that the RIPCre mouse is intrinsically glucose intolerant [12] . Our current studies have utilised a Pdx1-cre mouse to delete Irs2 only in the pancreas, thus generating PIrs2KO mice. These animals do not display obesity, insulin resistance or hyperinsulinaemia and therefore represent a good model for determining the role of IRS2 in the pancreas in the absence of these phenotypes. Furthermore, the Pdx1-cre allele alone does not impair glucose homeostasis. Our analysis shows that PIrs2KO mice have a reduced beta cell mass with reduced beta cell proliferation, confirming the key role of IRS2 in this process. No alteration in beta cell mass was seen before weaning, consistent with previous observations [8] [9] [10] demonstrating that IRS2 is not required for beta cell development. Our findings also suggest that IRS2-dependent mechanisms are required not only for beta cell compensation under conditions of increased insulin The absence of insulin resistance in our model also permitted analysis of the effects of Irs2 deletion upon insulin secretory function. Insr-, Igf1r-and Irs1-null islets display defective glucose-stimulated insulin release in vitro [6, 21, 22] . In contrast, in both global Irs2-null mice and RIPCreIrs2KO mice, insulin secretion from isolated islets has been reported to be enhanced [4, 9] . While the basis for the discordance in these observations is unclear, they potentially suggest that IRS2 signalling has a negative effect upon insulin synthesis and secretion or that development of islets under conditions of insulin resistance caused by Irs2 deficiency in other tissues programmes the islets to hypersecrete insulin. However, we found that GSIS in PIrs2KO mice is reduced both in vivo and in vitro, suggesting that IRS2 pathways are required for either insulin synthesis or secretion. These findings are consistent with the reported role of INSR, IGF1R and IRS1 in these processes and with a study demonstrating that IRS2/ phosphatidylinositol 3-kinase/p70S6 kinase signalling regulates insulin gene transcription [23] . The combined effect of reduced beta cell mass and impaired insulin secretion resulted in impaired glucose tolerance and fed hyperglycaemia in PIrs2KO mice. However, these animals displayed normal fasting blood glucose levels and never developed the progressive diabetes seen in Irs2 global-null mice. These findings demonstrate that the interplay between beta cell dysfunction and peripheral insulin resistance is required for the development of diabetes in the Irs2-null mouse model.
Insulin signalling has been implicated in pancreatic alpha cell function but the role of this pathway has not been directly addressed genetically in mice. For example, insulin inhibits GCG secretion from mouse clonal alpha cell lines and primary islets in vitro [24] . RNA interferencemediated knockdown of Insr expression in the same cell types impairs GCG secretion in response to reduced glucose levels [25] . Therefore disruption of insulin signalling in alpha cells might be expected to lead to loss of the repression of GCG secretion by insulin or a failure to increase GCG release under conditions of hypoglycaemia. Here we demonstrate a novel key role for IRS2 in the maintenance of alpha cell mass, which in turn is reflected in the reduced pancreatic GCG peptide and mRNA content seen in PIrs2KO mice. The reduced GCG levels in our model may also underlie the mild impairment in the recovery in glucose levels during insulin tolerance testing in PIrs2KO mice and the absence of hyperglucagonaemia may also contribute to the lack of progressive diabetes in these animals. We also demonstrate lower SST levels in the islets of PIrs2KO mice suggesting reduced numbers of delta cells in these animals. Our findings that both beta cell and alpha cell mass are reduced indicate that IRS2 signalling may be important in a common endocrine precursor cell type or for maintaining proliferation in mature islet endocrine cells.
Beta cell deletion of Insr, Igf1r and Irs1 impairs glucosestimulated insulin secretion. Defects in glucose-stimulated calcium mobilisation are thought to be a component of this abnormality. For example, Insr-, Igf1r-and Irs1-deficient islets display reduced increases in intracellular calcium flux, which, in the case of Irs1-null islets, are thought to be in part due to decreased expression of sarco(endo)plasmic reticulum Ca 2+ -ATPase expression [7, 26, 27] . PIrs2KO beta cells also showed impaired calcium mobilisation in response to glucose, suggesting that IRS2 signalling is also a component of this mechanism.
Analysis of gene expression patterns in PIrs2KO islets revealed that Irs1 mRNA levels were unaltered, demonstrating there was no compensatory upregulation of this gene, which contrasts with the upregulation of Irs2 reported in Irs1-null islets [28] . Reduced expression of Pdx1 has been reported in Irs2 global-null and RIPCreIrs2KO mice and upregulation of Pdx1 in the beta cell rescues the beta cell failure in Irs2 global-null mice [10, 29] . These findings, together with those demonstrating that Pdx1 haploinsufficiency blunts beta cell compensation in other models of insulin resistance [30] , have led to the suggestion that INSR and IRS2 signalling is required for the normal expression and function of PDX1. However, we found normal expression of Pdx1 in islets and our findings do not support this conclusion. Indeed others have also reported that Pdx1 expression is normal in Irs2-null beta cells and that differences in expression may be mouse strain dependent [31] . In contrast, we found reduced Slc2a2 expression with concomitant reduction in protein production in PIrs2KO islets and this may further impair beta cell function. While the mRNA expression of two other transcription factors which are critical for beta cell function, Foxo1 and Nkx6-1, was attenuated, the reductions in the production of these proteins was modest. However, it is possible that such small reductions in a number of key beta cell genes also contribute to the beta cell phenotype in PIrs2KO mice.
Studies with our colony of RIPCre (B6.Cg-tg(Ins2-cre) 25Mgn/J) transgenic mice failed to detect glucose intolerance in this strain in either sex up to 24 weeks of age, in contrast to a recent report [12] . While we originally obtained RIPCre mice from the Jackson Laboratory, these animals were intercrossed for several generations with either 129Sv/C57Bl/6 or 129Sv/C57Bl/6/BALB/c hybrids used to generate floxed alleles and these latter strains were not obtained from the same source. These findings taken together with the normal glucose homeostasis observed in the Pdx1-cre mice in our studies suggest that Cre recombinase expression in beta cells does not impair their function. Recently it has been demonstrated that C57Bl/6J mice descended from the colony established at the Jackson Laboratory have a spontaneous in-frame five-exon deletion in the nicotinamide nucleotide transhydrogenase gene [32] . This is associated with glucose intolerance and reduced insulin secretion, which may contribute to the phenotypes reported in some studies [32] . These findings further emphasise the influence of genetic background on metabolic phenotypes when complex gene targeting strategies are employed.
In summary, through the generation of PIrs2KO mice, we have demonstrated a key role for IRS2 signalling events in the regulation of beta cell function without the confounding factors of hypothalamic dysfunction and insulin resistance. We also reveal a more general role for IRS2 signalling in the regulation of other pancreatic cells types such as alpha cells.
